Full-Time

Logistics Manager

Deadline 9/1/27
Meridian Bioscience

Meridian Bioscience

501-1,000 employees

Develops and distributes diagnostic test kits

No salary listed

Memphis, TN, USA

In Person

Travel is required at less than 10%.

Bachelor's

Category
Operations & Logistics (1)
Required Skills
ERP
Supply Chain Management

Get referred to Meridian Bioscience

See people who can refer or advise you

Requirements
  • A bachelor's degree in supply chain, logistics, business, or a related field plus 5 or more years of experience in logistics, transportation, or supply chain operations; alternatively, 10 or more years of equivalent experience in logistics and distribution environments.
  • At least 5 years of experience in shipping, transportation, or logistics management, including carrier management and freight coordination.
  • Experience managing inbound and outbound logistics, including supplier shipments and customer deliveries in a manufacturing or regulated environment.
  • Working knowledge of enterprise resource planning systems and transportation or shipping systems.
  • Demonstrated experience managing logistics-related customer issues, including root cause analysis and corrective actions.
  • Strong analytical skills with the ability to evaluate freight costs, carrier performance, and service levels.
  • Experience with cold chain logistics, including temperature-controlled shipping, packaging, and monitoring requirements.
  • Ability to work flexible hours as needed to support shipping schedules, carrier coordination, and issue resolution.
  • Ability to lift up to 75 pounds of supplies or components daily.
  • Ability to walk up and down flights of stairs throughout the workday in a multi-location facility.
  • Ability to stand or sit for long periods and reach, stoop, lift, bend, push, and pull carts and utility bins during the work shift.
  • Ability to work inside refrigerators and freezers with temperatures ranging from 2°C to -80°C.
  • Ability to wear protective equipment, including lab coats, safety glasses, latex gloves, and hair nets.
  • Ability to analyze, concentrate, and interpret processes routinely while remaining focused in a fast-paced open environment.
  • Less than 10% travel is required.
Responsibilities
  • Lead all outbound shipping operations to ensure accurate, timely, and compliant delivery of finished goods to customers and distribution partners.
  • Coordinate inbound logistics from suppliers in partnership with Procurement to ensure timely material delivery and resolve transportation-related issues.
  • Manage parcel, less-than-truckload, full-truckload, and international freight carrier relationships to optimize cost, service, and delivery performance.
  • Negotiate freight rates and evaluate carrier performance using metrics such as on-time delivery, cost, and service quality.
  • Oversee import and export activities, including coordination with customs brokers and freight forwarders to ensure timely clearance and compliance with trade regulations.
  • Ensure shipping and transportation activities comply with Food and Drug Administration, Quality System Regulation, International Organization for Standardization, and company requirements, including documentation, labeling, and traceability.
  • Own and resolve logistics-related customer complaints, including late shipments, damages, and delivery discrepancies, with timely communication and resolution.
  • Conduct root cause analysis on shipping and transportation issues and implement corrective and preventive actions.
  • Partner with Warehouse Operations, Procurement, Customer Service, Quality, and Manufacturing to align logistics activities with business needs.
  • Monitor and report key performance indicators, including on-time delivery, transit times, freight costs, carrier performance, and complaint trends.
  • Identify and implement process improvements and automation to enhance efficiency, reduce costs, and improve service levels across logistics operations.
  • Ensure accurate and timely transactions in enterprise resource planning and shipping systems related to transportation and shipment tracking.
  • Lead and develop shipping personnel, set performance expectations, and foster accountability, compliance, and continuous improvement.
Desired Qualifications
  • Experience managing inbound and outbound logistics in a manufacturing or regulated environment, with Food and Drug Administration experience preferred.
  • Experience with Infor XA or MAPICS preferred.
  • Experience with domestic and international shipping, including customs processes, documentation, and coordination with brokers and freight forwarders.
  • Knowledge of Harmonized Tariff Schedule codes, import/export regulations, and resources such as USDA IREGS.

Meridian Bioscience develops, manufactures, markets and distributes diagnostic test kits, rare reagents, specialty biologicals and components for life science and agri-bio research. Its diagnostic products are designed for use outside the body with minimal equipment, delivering accurate and fast results to aid early diagnosis of infections and lead poisoning. The company maintains an end-to-end platform from development to distribution and holds strong positions in gastrointestinal and upper respiratory infections as well as blood lead level testing, while its products also serve as components in other diagnostics. Its goal is to improve patient well-being and reduce health care costs by providing accessible, reliable diagnostics and research materials.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Cincinnati, Ohio

Founded

1977

Get referred to Meridian Bioscience

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Alethia IVDR clearance opens more European hospital and lab purchasing channels in 2026.
  • June 26, 2024 lyophilized NGS launch and February 18, 2026 expansion deepen life-science sales.
  • New CEO Andy Kitzmiller and CFO Julie Smith, named October 14, 2025, sharpen execution.

What critics are saying

  • SD Biosensor and SJL own Meridian since January 31, 2023, limiting employee equity upside.
  • October 14, 2025 CEO reset signals pressure to accelerate growth after ownership change.
  • 4bases partnership exposes Meridian to partner-dependent commercialization if KaryoSolver adoption stalls.

What makes Meridian Bioscience unique

  • Alethia IVDR certification on February 23, 2026 validates broad European molecular assay reach.
  • Meridian's lyophilized NGS kits eliminate cold-chain shipping, a rare workflow advantage.
  • Health Canada licensed Alethia CMV on July 8, 2026, expanding regulated diagnostics breadth.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

8%

2 year growth

8%
Associated Press
Jul 14th, 2026
Meridian Bioscience gains Health Canada licence for rapid CMV diagnostic assay

Meridian Bioscience has received Health Canada licensing for its Alethia CMV assay, expanding its molecular diagnostic offerings in the Canadian market. The assay joins Meridian's existing Alethia menu, which includes tests for C. difficile, Group A Strep, Group B Strep, malaria, Mycoplasma, and pertussis. The Alethia platform uses LAMP technology to deliver molecular results in under an hour. The CMV assay enables early detection of congenital cytomegalovirus, which affects one in 200 babies annually. Nearly one in four women carry CMV, the most common congenital infection transmitted during pregnancy. The assay uses saliva samples for congenital CMV testing. Meridian Bioscience is a privately held life science company headquartered in Cincinnati, Ohio, serving customers in over 70 countries.

Business Wire
Jun 10th, 2026
Meridian and 4bases partner to scale cytogenetics NGS assay with ambient-stable reagents

Meridian Bioscience has partnered with 4bases to enable global deployment of KaryoSolver, a next-generation cytogenetics assay, through advanced reagent stabilisation technology. The collaboration addresses a critical barrier to scaling NGS workflows: the cold-chain requirements of conventional liquid-based library preparation solutions. Meridian's lyophilisation platform stabilises KaryoSolver's NGS library preparation components, enabling ambient-temperature shipping and storage whilst maintaining diagnostic performance. The technology eliminates refrigerated logistics, extends shelf life, and simplifies global distribution. KaryoSolver consolidates structural variant detection into a single assay with integrated analysis, delivering genomic insights within hours versus days for traditional workflows. The stabilisation breakthrough allows 4bases to expand access to comprehensive genetic diagnosis whilst reducing costs and operational complexity across international markets. Both companies will exhibit at the European Human Genetics Conference in Gothenburg this June.

4bases
Jun 10th, 2026
4bases is happy to announce a collaboration agreement with Meridian Bioscience.

4bases is happy to announce a collaboration agreement with Meridian Bioscience. Ambient-stable NGS workflows, enabled by Meridian's lyophilization expertise, expand global access to 4bases' KaryoSolver(TM), a platform for rapid structural variant analysis. The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced a collaboration with 4bases SA focused on one critical objective: expanding the accessible market and enhancing the global deployment of KaryoSolver(TM), a next-generation cytogenetics assay, through advanced assay stabilization. KaryoSolver(TM) represents a significant step forward in cytogenetics. Traditional workflows rely on multiple complementary tests, often taking days to deliver a complete picture. In contrast, KaryoSolver(TM) consolidates structural variant detection into a single assay with integrated data analysis, providing actionable genomic insights within hours. However, bringing this innovation to a global market requires overcoming a critical barrier: reagent stability. Conventional liquid-based NGS library preparation solutions are inherently limited by short shelf life, creating significant challenges across the distribution chain, including the cost and complexity of refrigerated shipping and storage that have historically restricted scalable global expansion. Meridian addressed this challenge through its advanced reagent stabilization platform, combining formulation science with optimized enzyme lyophilization technology. By stabilizing the NGS library preparation components, Meridian enabled KaryoSolver(TM) to be shipped and stored at ambient temperatures, eliminating cold-chain requirements, extending shelf life, and simplifying inventory management across the global distribution channels. In addition, lyophilization streamlines manufacturing, supporting more efficient and scalable production. "Our platform technology enabled the transition of the assay into a room-temperature stable format while preserving the performance characteristics required for molecular diagnostics," said Florent Chang-Pi-Hin, Vice President, Research and Development at Meridian Life Science. "By removing cold-chain constraints without sacrificing assay integrity, we're helping expand access to reliable testing worldwide." In this fruitful collaboration, Meridian and 4bases R&D teams joined efforts to optimize Meridian's Lyophilized NGS Enzymatic DNA Fragmentation reagents for the development of a kit to be integratied into 4bases' Oxford Nanopore Technologies workflow, ensuring reliable and efficient sample preparation within the broader assay system. "The idea behind KaryoSolver(TM) is to simplify access to comprehensive genetic diagnosis, and Meridian's expertise in stabilization has been transformative," said Fabio Grandi, COO & Co-Founder at 4bases. "Short shelf life and cold-chain requirements previously limited how far and how efficiently we could scale. With lyophilization, we can now reliably supply our global customers while simplifying logistics, reducing costs, and accelerating the adoption of KaryoSolver(TM) as a rapid, single-workflow solution for cytogenetics." Together, Meridian and 4bases are removing key barriers to advanced genomic testing, pairing breakthrough assay design with the stability, scalability, and operational efficiency required for effective global deployment. 4bases and Meridian Bioscience will both be exhibiting at the upcoming European Human Genetics Conference (ESHG) on June 13-16 in Gothenburg, Sweden, where attendees will have the possibility to learn more about the companies' collaboration and latest advances in ambient-stable next-generation sequencing workflows and cytogenetics solutions. Additional event details, including opportunities to schedule meetings with the Meridian Bioscience and 4bases teams during ESHG, can be found at https://4bases.ch and Meridian Bioscience's events page. Share:

LinkedIn
May 7th, 2025
Excited to announce a strategic investment in heva — an AI-powered… | Raches Ella | 15 comments

Excited to announce a strategic investment in heva — an AI-powered platform transforming cross-border healthcare access! ✈️🌍 India is a premier destination for medical tourism, and heva, founded by Varun & Hector is solving the fragmentation that limits its growth. To healthcare providers: heva helps you focus on delivering world-class care — while they connect you to patients globally. | 15 comments on LinkedIn

PR Newswire
Mar 6th, 2025
Meridian Bioscience Congratulates Catherine Lufkin For Receiving Pure Earth'S 2025 "Force Of Nature" Award

CINCINNATI, March 6, 2025 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, proudly congratulates Catherine Lufkin, Senior Director, Global Point of Care, on being honored with Pure Earth's 2025 "Force of Nature" Award. This prestigious recognition celebrates her leadership and dedication to advancing environmental health, particularly in the fight against lead poisoning.Lufkin is being recognized at Pure Earth's International Women's Day celebration for her unwavering commitment to ensuring access to fast, accurate blood lead testing in communities impacted by lead contamination. Her leadership has been instrumental in Meridian's partnership with Pure Earth, which has provided LeadCare® II blood lead testing technology to under-resourced communities worldwide since 2016. Her dedication to advancing lead testing was also a driving force behind Meridian winning the CDC's Lead Detect Prize, a prestigious competition that fostered the development of innovative, rapid lead detection technologies to enhance public health efforts."We are immensely proud of Catherine's achievements and this well-deserved recognition," said Tony Serafini-Lamanna, President of Meridian Bioscience Diagnostics. "Her work exemplifies our mission to improve global health through innovation and collaboration. In our ongoing partnership with Pure Earth, we remain committed to reducing lead exposure and its harmful effects on vulnerable populations."The LeadCare II system, the only CLIA-waived point-of-care blood lead testing system, is a vital tool in Pure Earth's global efforts to combat lead poisoning